2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sjogren's Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cytarabine
906
Cyclophosphamide
900
fludarabine
525
venetoclax
489
fludarabine phosphate
468
Azacitidine
461
Rituximab
431
Methotrexate
420
Etoposide
320
Filgrastim
299
Busulfan
296
Dexamethasone
287
Vincristine
286
Daunorubicin
284
Peripheral Blood Stem Cell Transplantation
258
Whole-Body Irradiation
243
Mycophenolic Acid
232
Decitabine
230
Granulocyte Colony-Stimulating Factor
227
Tacrolimus
220
Imatinib Mesylate
211
Idarubicin
205
Melphalan
202
Cyclosporine
182
Doxorubicin
178
Radiotherapy
169
Prednisone
164
Dasatinib
163
Mitoxantrone
161
Lenalidomide
160
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
belimumab
×
Other hematologic neoplasm
×
Clear all
NCT06410833
2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4
Recruiting
15 enrolled